Cheaper Alternatives to Mounjaro: A Doctor's Honest Guide for Indian Patients

Editorial notice: This article is general educational content about prescription weight-management treatments available in India. It is not medical advice, not a recommendation to use any specific medication, and not a promotion of any brand. NuvaHealth does not sell, stock, or dispense any medication. All treatment decisions must be made in a private consultation with a qualified doctor who has reviewed your complete medical history. Prescription medicines discussed here are Schedule H drugs and are available only with a valid prescription from a licensed pharmacy.

Why Mounjaro Costs So Much in India

Mounjaro (tirzepatide) launched in India in 2025 with monthly costs in the range of ₹13,000 to ₹26,000, depending on the dose. For a treatment that typically needs to continue for many months — or indefinitely — that adds up to one or two lakh rupees per year. For most middle-class Indian families, that is simply not sustainable.

The high price is not a profiteering decision; it reflects a real situation. Tirzepatide is still under patent. It is manufactured abroad, imported into India, and priced at a global level adjusted slightly for the Indian market. No generic version exists yet — and is not expected before approximately 2027–2028, after which prices are likely to fall by 50 to 70 percent, in line with what has happened with other once-patented diabetes and weight-loss molecules.

Until then, patients reasonably ask: What are the cheaper alternatives? The honest answer is that several genuinely cheaper, legal, prescription options exist — and a doctor's job is to find the one that fits your medical situation and your budget, not the most expensive one.

Alternative 1: Lower-Dose Mounjaro Itself

Before considering a different molecule, the first lever a doctor can use is the dose. Mounjaro is sold in several strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg per dose). The price per pen differs sharply by dose, with the lowest doses costing meaningfully less per month than the higher doses.

For many patients, a lower maintenance dose is medically reasonable — particularly when significant weight has already been lost, or when side effects make a higher dose intolerable. Some patients do very well at 5 mg or 7.5 mg long-term and never need to escalate. Discussing with a doctor whether you genuinely need to climb to the maximum dose can cut your monthly cost almost in half, without changing the molecule at all.

Alternative 2: Semaglutide-Based Options

The other major GLP-1 family is built around semaglutide — the active ingredient in Ozempic (a once-weekly injection licensed for type 2 diabetes), Wegovy (a once-weekly injection licensed for weight management) and Rybelsus (a once-daily oral tablet).

In Indian clinical practice, semaglutide-based products generally cost less than tirzepatide for an equivalent month of treatment. They also have a longer track record — semaglutide was the first widely-used GLP-1 weight-loss drug, with extensive published data on long-term efficacy and safety.

Head-to-head, tirzepatide tends to produce slightly greater average weight loss than semaglutide in trials. But "slightly more" weight loss at double the price is not always the right trade-off for an individual patient. For many Indians, a semaglutide-based option delivers most of the benefit at a fraction of the cost. The oral tablet (Rybelsus) is also useful for patients who are unwilling or unable to inject.

Alternative 3: Older GLP-1 Medications (Liraglutide)

Before semaglutide and tirzepatide came an earlier generation of GLP-1 drugs based on liraglutide — sold as Saxenda for weight management and Victoza for type 2 diabetes. Liraglutide is a once-daily injection rather than once-weekly.

Liraglutide produces less weight loss on average than semaglutide or tirzepatide — typically in the range of 5 to 8 percent body weight, versus 12 to 22 percent for the newer molecules. But it has been studied for far longer, it is widely available in India, and it is meaningfully cheaper than Mounjaro. Generic liraglutide has also entered the Indian market, bringing the price down further. For a patient who needs moderate weight loss and cannot afford newer options, liraglutide remains a legitimate, doctor-prescribed choice.

Alternative 4: Non-GLP-1 Prescription Options

Not every patient who wants to lose weight needs a GLP-1 medication. Other prescription options have existed for years and cost a fraction of what GLP-1 drugs cost:

• Orlistat — works by blocking the absorption of dietary fat. It is widely available in India, costs a few hundred rupees a month, and produces modest weight loss (around 3 to 5 percent body weight) when paired with a reduced-fat diet. It is not a GLP-1, but for the right patient it works.
• Metformin — primarily a diabetes drug, but often prescribed for people with PCOS, prediabetes or insulin resistance. It is one of the cheapest prescription medicines in India, well tolerated, and produces small but meaningful weight loss in people whose weight is driven by insulin resistance.
• Treatment of an underlying cause — if uncontrolled hypothyroidism, untreated PCOS, severe sleep apnoea or chronic stress are driving your weight, the cheapest "weight-loss medication" is the one that fixes the actual problem. Getting these conditions properly treated can be transformative — and the underlying medications are usually inexpensive and covered by insurance.

Alternative 5: The Generic Wave Coming in 2027–2028

Patents on the newer GLP-1 molecules are scheduled to expire in stages over the next several years. Generic semaglutide is expected in India earlier than generic tirzepatide. Indian pharmaceutical companies have a strong track record of producing affordable generics — historically, diabetes drug prices have dropped by 50 to 80 percent once generics enter the market.

For patients whose weight loss is not medically urgent, it can be reasonable to focus on lifestyle and lower-cost prescription options now, and reassess in 2027–2028 when the cost landscape changes meaningfully. A doctor can help you weigh this timing decision.

What You Should NOT Do To Save Money

Several "cheaper" routes are circulating in WhatsApp groups, Instagram ads and the dark corners of e-commerce. Avoid all of them.

• Compounded "GLP-1" preparations — these are mixtures sold by unregulated pharmacies or online sellers, often claiming to contain semaglutide or tirzepatide. In India they are illegal, unverified, and have been linked to serious adverse events worldwide, including dosing errors and contamination.
• Gray-market imports — pens bought from sellers who source them from other countries without a prescription. You have no way to verify storage (these drugs must stay refrigerated), authenticity, or expiry.
• "Research peptide" versions sold by laboratory-supply websites — these are not pharmaceutical-grade and not intended for human use, despite what the seller implies.
• Veterinary versions of any weight-loss molecule — a recurring and dangerous internet "hack" that has caused real harm.
• Doubling up on someone else's prescription — using a family member's leftover pens, or sharing a prescription. Both are illegal and medically unsafe.

Saving 50 percent on a medicine that turns out to be fake, contaminated, mis-dosed or unrefrigerated is not a saving. It is a serious risk to your health, with no recourse if something goes wrong.

The Cheapest Effective Option Is Personal

There is no single "cheaper alternative" that works for everyone. The right cheaper option depends on:

1. How much weight you need to lose — bigger goals may justify a more powerful (and costlier) molecule; modest goals often do not.
2. Your other conditions — diabetes, PCOS, fatty liver, hypertension may shift which drug your insurance or doctor prefers.
3. Your tolerance for side effects — some patients tolerate one GLP-1 better than another, which can change the practical choice.
4. Whether you prefer injections or tablets — the oral semaglutide option exists for those who avoid needles.
5. How long you plan to continue treatment — short-term and long-term plans have different economics.

An honest doctor — one who is not selling you anything — will walk you through these trade-offs, name the prices, and help you pick the cheapest medically appropriate option, not the most profitable one.

Lifestyle Is Not a "Cheaper Alternative" — It Is the Foundation

Every effective weight-loss treatment, expensive or cheap, works better when paired with sustainable lifestyle changes. Crash diets fail, but the foundational interventions — adequate protein (see our guide to the Indian protein paradox), strength training, consistent walking, sleep, and stress management — work for everyone. They cost nothing, they improve every clinical outcome, and they make any medication you eventually take more effective and more durable.

Patients who lose weight on lifestyle alone, or who lose weight on a cheaper drug because their foundation is solid, are not failing. They are succeeding for less money.

Get an Honest, Personalised Cost Plan — Talk to a Doctor on NuvaHealth

NuvaHealth connects you with licensed Indian doctors who will look at your full picture — your weight, your conditions, your budget, and your goals — and tell you the truth about which medication, if any, is right for you, and what it will actually cost month-to-month. No upselling. No pharmacy commissions. Just a clear, qualified answer.

Start your free assessment on NuvaHealth today and get a personalised, honest plan.